{"id":4197,"company":{"country":"US","currency":"USD","exchange":"NEW YORK STOCK EXCHANGE, INC.","ipo":"1991-04-24","marketCap":18030.2,"name":"Laboratory Corporation of America Holdings","phone":"13362291127.0","outstanding":84.9,"symbol":"LH","website":"https://www.labcorp.com","industry":"Health Care"},"price":225.0075,"year":2024,"month":8,"day":10,"weekday":"Saturday","title":"Potential Impact of Technology Disruptions on Laboratory Corporation of America Holdings and Traditional Industries","date":"2024-08-10","url":"/posts/2024/08/10/LH","content":[{"section":"Introduction","text":"LabCorp is a leading provider of clinical laboratory and end-to-end drug development services. Traditional industries like healthcare and diagnostics heavily rely on LabCorp's services. However, the emergence of technology disruptions may pose challenges and opportunities for LabCorp and the stocks within these industries."},{"section":"Impact on LabCorp","text":"Technology disruptions can significantly impact LabCorp's operations and stock. The integration of innovative technologies such as artificial intelligence (AI), machine learning, and automation could enhance LabCorp's efficiency, accuracy, and scalability. This may lead to cost savings and improved turnaround times for test results. LabCorp's ability to adapt and incorporate these technologies into its operations will determine its competitive advantage and potential stock performance."},{"section":"Changing Competitive Landscape","text":"Technology disruptions can alter the competitive landscape within the healthcare and diagnostics industry. As new players enter the market with disruptive solutions, LabCorp may face increased competition. Startups or tech companies offering direct-to-consumer testing, telemedicine platforms, or decentralized diagnostic tools could challenge LabCorp's market share. LabCorp would need to innovate and leverage its existing infrastructure to remain competitive and protect its stock value."},{"section":"Regulatory Challenges","text":"Technology disruptions often outpace regulatory frameworks, creating challenges for traditional industries. LabCorp may encounter regulatory hurdles as new technologies and diagnostic methods emerge. Compliance with evolving regulations and ensuring data privacy and security will be crucial for LabCorp's operations and investors' confidence. Adapting to regulatory changes effectively will impact LabCorp's stock and industry reputation."},{"section":"Opportunities for Collaboration","text":"Despite potential challenges, technology disruptions can also bring opportunities for collaboration within the industry. LabCorp could partner with technology companies or startups to leverage their innovative solutions and expand their service offerings. Collaborations may allow LabCorp to access new markets, tap into emerging technologies, and enhance its competitive position. Successful partnerships could positively impact LabCorp's stock and industry influence."},{"section":"Conclusion","text":"Technology disruptions pose both risks and opportunities for Laboratory Corporation of America Holdings and traditional industries. LabCorp's ability to adapt, innovate, and collaborate will play a pivotal role in navigating the evolving landscape. Investors should monitor LabCorp's efforts to incorporate technology advancements, manage regulatory challenges, and foster collaborations to assess its potential stock performance."}],"tags":["LongSignals","Long","Health Care"],"news":[{"category":"company","date":1723026039,"headline":"Labcorp Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags","id":129200021,"image":"https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","symbol":"LH","publisher":"Yahoo","summary":"Labcorp Holdings ( NYSE:LH ) Second Quarter 2024 Results Key Financial Results Revenue: US$3.22b (up 6.2% from 2Q...","url":"https://finance.yahoo.com/news/labcorp-holdings-second-quarter-2024-102039133.html"},{"category":"company","date":1723021260,"headline":"Insider Sale: EVP, CIO \u0026 CTO Lance Berberian Sells 12,093 Shares of Labcorp Holdings Inc (LH)","id":129211252,"image":"","symbol":"LH","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3590009124"},{"category":"company","date":1722919625,"headline":"Labcorp wins FDA OK for pan-solid tumor liquid biopsy","id":129191186,"image":"https://www.medtechdive.com/imgproxy/TPIHSON8ct2ZPBveXmP9IhZmUFKSd9N-UJl1N6JFi4E/g:ce/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL0lNR18yMDk2LmpwZw==.webp","symbol":"LH","publisher":"Yahoo","summary":"Shakti Ramkissoon, Labcorp’s medical lead for oncology, said the test could allow laboratories and oncologists to profile solid tumors when tissue samples are limited or unavailable.","url":"https://www.medtechdive.com/news/labcorp-fda-de-novo-solid-tumor-biopsy/723395/"},{"category":"company","date":1722855600,"headline":"Labcorp Finalizes Acquisition of Select Assets of Invitae","id":129149464,"image":"https://media.zenfs.com/en/prnewswire.com/dfb2a169dcf74a375ce32bd7ba958549","symbol":"LH","publisher":"Yahoo","summary":"Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of Invitae (OTC:NVTAQ), a leading medical genetics company. Together, Labcorp and Invitae will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.","url":"https://finance.yahoo.com/news/labcorp-finalizes-acquisition-select-assets-110000146.html"},{"category":"company","date":1722845533,"headline":"FDA grants De Novo authorisation for Labcorp’s liquid biopsy test","id":129148521,"image":"https://www.medicaldevice-network.com/wp-content/uploads/sites/23/2024/08/md1-PlasmaFocus.jpg","symbol":"LH","publisher":"Yahoo","summary":"The PGDx elio plasma focus Dx aims to identify guideline-recommended biomarkers.","url":"https://www.medicaldevice-network.com/news/fda-novo-labcorps-biopsy/"},{"category":"company","date":1722840840,"headline":"Labcorp price target raised by $20 at BofA, here's why","id":129154185,"image":"","symbol":"LH","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3586489220"},{"category":"company","date":1722838020,"headline":"Labcorp completes acquisition of select assets of Invitae","id":129161970,"image":"","symbol":"LH","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3586456770"},{"category":"company","date":1722831960,"headline":"Buy Rating Reaffirmed for LabCorp Amid Strong Diagnostics Performance and Strategic Acquisitions","id":129161971,"image":"","symbol":"LH","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3586397741"},{"category":"company","date":1722831480,"headline":"Labcorp’s Strong Performance and Growth Prospects Affirm Buy Rating","id":129161972,"image":"","symbol":"LH","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3586393364"},{"category":"company","date":1722828240,"headline":"Analysts’ Top Healthcare Picks: Laboratory (LH), Humana (HUM)","id":129152121,"image":"","symbol":"LH","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3586364623"},{"category":"company","date":1722825600,"headline":"Buy Rating Reaffirmed for LabCorp with Strong Q2 Performance and Positive 2024 Outlook","id":129161976,"image":"","symbol":"LH","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3586344749"},{"category":"company","date":1722663000,"headline":"Wall Street Breakfast: What Moved Markets","id":129129631,"image":"","symbol":"LH","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3584815998"},{"category":"company","date":1722661531,"headline":"Decoding Labcorp Holdings Inc (LH): A Strategic SWOT Insight","id":129129314,"image":"https://media.zenfs.com/en/us.finance.gurufocus/f6b09a6b31fec7a0ebb12603c72f12c6","symbol":"LH","publisher":"Yahoo","summary":"Unveiling the Financial and Strategic Position of Labcorp Holdings Inc (LH)","url":"https://finance.yahoo.com/news/decoding-labcorp-holdings-inc-lh-050531921.html"},{"category":"company","date":1722618758,"headline":"Health Care Stock Soars Past Buy Point After Boosting Buyback","id":129105162,"image":"https://media.zenfs.com/en/ibd.com/2b521c9cdb5da94fff593b1b78dbc506","symbol":"LH","publisher":"Yahoo","summary":"Laboratory Corporation of America gapped up and broke out past a buy point of 234.09.  Labcorp stock was one of the few stocks to break out as the stock market plunged Friday.  Labcorp shares surged more than 8% Thursday in the strongest volume since April 25 after second-quarter results beat Wall Street estimates.","url":"https://finance.yahoo.com/m/eed166b9-4a7b-3e12-b7e5-33ce36fc9901/health-care-stock-soars-past.html"},{"category":"company","date":1722601800,"headline":"Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx","id":129105164,"image":"https://media.zenfs.com/en/prnewswire.com/6b12e6bb870e77d6e9aa057a621a7a84","symbol":"LH","publisher":"Yahoo","summary":"Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it has received De Novo marketing authorization from the U.S. Food and Drug Administration (FDA) for PGDx elio™ plasma focus Dx – the industry's first and only kitted, pan-solid tumor liquid biopsy test.","url":"https://finance.yahoo.com/news/labcorp-receives-fda-novo-marketing-123000260.html"},{"category":"company","date":1722594960,"headline":"LabCorp Analysts Boost Their Forecasts After Better-Than-Expected Earnings","id":129116927,"image":"","symbol":"LH","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3583390002"},{"category":"company","date":1722594694,"headline":"Q2 2024 Labcorp Holdings Inc Earnings Call","id":129105166,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"LH","publisher":"Yahoo","summary":"Q2 2024 Labcorp Holdings Inc Earnings Call","url":"https://finance.yahoo.com/news/q2-2024-labcorp-holdings-inc-103134910.html"},{"category":"company","date":1722591180,"headline":"Labcorp gets FDA approval for PGDx elio plasma focus Dx","id":129116928,"image":"","symbol":"LH","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3583305076"},{"category":"company","date":1722587400,"headline":"Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio? plasma focus Dx","id":129116930,"image":"","symbol":"LH","publisher":"PR Newswire","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=0kerucph76"},{"category":"company","date":1722585300,"headline":"Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT), RegenXBio (RGNX) and Laboratory (LH)","id":129109674,"image":"","symbol":"LH","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3583174296"},{"category":"company","date":1722585000,"headline":"Morgan Stanley Reaffirms Their Buy Rating on Laboratory (LH)","id":129116934,"image":"","symbol":"LH","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3583170578"},{"category":"company","date":1722583980,"headline":"Labcorp's tumor liquid biopsy test granted FDA De Novo Marketing Authorization","id":129116935,"image":"","symbol":"LH","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3583148520"},{"category":"company","date":1722581700,"headline":"Labcorp price target raised by $20 at Truist, here's why","id":129116936,"image":"","symbol":"LH","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3583108047"},{"category":"company","date":1722581400,"headline":"Truist Financial Remains a Buy on Laboratory (LH)","id":129116937,"image":"","symbol":"LH","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3583103879"},{"category":"company","date":1722580680,"headline":"Labcorp price target raised by $10 at UBS, here's why","id":129116938,"image":"","symbol":"LH","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3583092607"},{"category":"company","date":1722578040,"headline":"Labcorp price target raised by $16 at Baird, here's why","id":129116939,"image":"","symbol":"LH","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3583049607"},{"category":"company","date":1722576780,"headline":"Labcorp price target raised by $36 at Barclays, here's why","id":129116940,"image":"","symbol":"LH","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3583033800"},{"category":"company","date":1722570060,"headline":"Analysts Offer Insights on Healthcare Companies: Laboratory (LH), Neurocrine (NBIX) and Becton Dickinson (BDX)","id":129112016,"image":"","symbol":"LH","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3582957870"},{"category":"company","date":1722538920,"headline":"Labcorp (LH) Q2 Earnings Surpass Estimates (revised)","id":129079328,"image":"https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307","symbol":"LH","publisher":"Yahoo","summary":"Labcorp (LH) beats on earnings and revenues in the second quarter, entering the second half of 2024 with robust momentum.","url":"https://finance.yahoo.com/news/labcorp-lh-q2-earnings-surpass-190200326.html"},{"category":"company","date":1722533519,"headline":"LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector","id":129079329,"image":"https://media.zenfs.com/en/Benzinga/809a77f1c278a3df2f6f257675425707","symbol":"LH","publisher":"Yahoo","summary":"Thursday, Laboratory Corp (NYSE:A) reported second-quarter 2024 adjusted EPS of $3.94, up from $3.42 a year ago, beating the consensus of $3.78. Sales increased 6.2% year-over-year to $3.22 billion, beating the consensus of $3.19 billion. The increase was due to organic revenue of 3.8%, acquisitions, and net of divestitures of 2.5%, partially offset by foreign currency translation of (0.1%). The 3.8% increase in organic revenue was driven by a 4.5% increase in the company’s organic Base Business","url":"https://finance.yahoo.com/news/labcorps-stock-soars-q2-performance-173159278.html"},{"category":"company","date":1722525305,"headline":"Labcorp Holdings Inc (LH) Q2 2024 Earnings Call Transcript","id":129074679,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"LH","publisher":"SeekingAlpha","summary":"Labcorp Holdings Inc (NYSE:NYSE:LH) Q2 2024 Results Conference Call August 1, 2024 9:00 AM ETCompany ParticipantsChristin OâDonnell - Vice President of...","url":"https://seekingalpha.com/article/4709338-labcorp-holdings-inc-lh-q2-2024-earnings-call-transcript"},{"category":"company","date":1722520020,"headline":"Labcorp (LH) Q2 Earnings Surpass Estimates, Margins Increase","id":129079331,"image":"https://media.zenfs.com/en/zacks.com/0e6e00119767dea571e2db52c929df03","symbol":"LH","publisher":"Yahoo","summary":"Labcorp (LH) beats on earnings and revenues in the second quarter, entering the second half of 2024 with robust momentum.","url":"https://finance.yahoo.com/news/labcorp-lh-q2-earnings-surpass-134700285.html"},{"category":"company","date":1722519035,"headline":"Compared to Estimates, Labcorp (LH) Q2 Earnings: A Look at Key Metrics","id":129079333,"image":"https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f","symbol":"LH","publisher":"Yahoo","summary":"The headline numbers for Labcorp (LH) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.","url":"https://finance.yahoo.com/news/compared-estimates-labcorp-lh-q2-133035946.html"},{"category":"company","date":1722514208,"headline":"Labcorp (LH) Beats Q2 Earnings and Revenue Estimates","id":129067035,"image":"https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94","symbol":"LH","publisher":"Yahoo","summary":"Labcorp (LH) delivered earnings and revenue surprises of 4.23% and 0.78%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?","url":"https://finance.yahoo.com/news/labcorp-lh-beats-q2-earnings-121008237.html"},{"category":"company","date":1722513901,"headline":"Meta Platforms, Ferrari, ConocoPhillips rise premarket; Arm, Moderna fall","id":129064317,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"LH","publisher":"Yahoo","summary":"Investing.com -- U.S. stock futures rose Thursday after the Federal Reserve opened the door for a rate cut in September, while the quarterly earnings season continued.","url":"https://finance.yahoo.com/news/meta-platforms-ferrari-conocophillips-rise-120501885.html"},{"category":"company","date":1722511734,"headline":"Labcorp beats Q2 profit and revenue estimates on demand for health tests","id":129067037,"image":"https://media.zenfs.com/en/reuters-finance.com/df112b9d959f4789d623bbe3b476a172","symbol":"LH","publisher":"Yahoo","summary":"Labcorp beat Wall Street expectations for second-quarter profit and revenue on Thursday on strong demand for its diagnostic tests, and raised its sales growth forecast for the year. The lab operator now sees annual sales growth between 6.4% and 7.5%, up from its previous range of 4.8% to 6.4%, boosted by demand for diagnostic health tests in the United States that has grown in recent quarters due to a post-pandemic recovery. The increased demand for medical care has benefited U.S. lab testing companies, including rival Quest Diagnostics, which raised its 2024 profit and revenue forecasts betting on strong demand for diagnostic kits.","url":"https://finance.yahoo.com/news/labcorp-beats-q2-profit-revenue-112854945.html"},{"category":"company","date":1722510524,"headline":"Labcorp: Q2 Earnings Snapshot","id":129067038,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"LH","publisher":"Yahoo","summary":"BURLINGTON, N.C. (AP) — Laboratory Corp. of America Holdings (LH) on Thursday reported second-quarter profit of $205.3 million. The Burlington, North Carolina-based company said it had net income of $2.43 per share.","url":"https://finance.yahoo.com/news/labcorp-q2-earnings-snapshot-110844051.html"},{"category":"company","date":1722509820,"headline":"Labcorp Announces 2024 Second Quarter Results","id":129067039,"image":"https://media.zenfs.com/en/prnewswire.com/dfb2a169dcf74a375ce32bd7ba958549","symbol":"LH","publisher":"Yahoo","summary":"Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the second quarter ended June 30, 2024 and updated full-year guidance.","url":"https://finance.yahoo.com/news/labcorp-announces-2024-second-quarter-105700810.html"},{"category":"company","date":1722503528,"headline":"Labcorp : Cautionary Statement Regarding Forward Looking Statements Q2 2024","id":129064916,"image":"","symbol":"LH","publisher":"Finnhub","summary":"Cautionary Statement Regarding Forward-Looking Statements This webcast contains forward-looking statements, including, but not limited to, statements with respect to the...","url":"https://finnhub.io/api/news?id=0f0c3a49efb3b3c862558fb16dd352c876b3ba4475d3c87f3acaebaf1a0af1ae"},{"category":"company","date":1722500160,"headline":"Buy Rating Reaffirmed for LabCorp Amid Strong Q2 Performance and Raised FY24 Revenue Guidance","id":129068541,"image":"","symbol":"LH","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3581111135"},{"category":"company","date":1722499260,"headline":"Fly Intel: Pre-market Movers","id":129068545,"image":"","symbol":"LH","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3581090971"},{"category":"company","date":1722493920,"headline":"Labcorp Holdings Inc (LH) Q2 2024 Earnings: EPS of $2.43 Beats Estimates, Revenue Hits $3.22 Billion","id":129068550,"image":"","symbol":"LH","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3580977266"},{"category":"company","date":1722493620,"headline":"Labcorp cuts FY24 adjusted EPS view to $14.30-$14.90 from $14.45-$15.35","id":129068551,"image":"","symbol":"LH","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3580971955"},{"category":"company","date":1722493380,"headline":"Labcorp reports Q2 adjusted EPS $3.94, consensus $3.78","id":129068553,"image":"","symbol":"LH","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3580968895"},{"category":"company","date":1722492120,"headline":"Laboratory Corporation of America beats top-line and bottom-line estimates; updates FY24 outlook","id":129068555,"image":"","symbol":"LH","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3580949783"},{"category":"company","date":1722441480,"headline":"What's in Store for These 4 MedTech Stocks in Q2 Earnings?","id":129042674,"image":"https://media.zenfs.com/en/zacks.com/e729d5a07f148302369676bf26b14bf7","symbol":"LH","publisher":"Yahoo","summary":"Here is a sneak peek into how four MedTech companies, LH, BIO, TFX and BRKR, are expected to fare in their second-quarter results, slated to be released tomorrow.","url":"https://finance.yahoo.com/news/whats-store-4-medtech-stocks-155800022.html"},{"category":"company","date":1722425220,"headline":"Laboratory Corporation of America Q2 2024 Earnings Preview","id":129054644,"image":"","symbol":"LH","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3579437253"},{"category":"company","date":1722424260,"headline":"Labcorp Holdings Inc (LH) Q2 2024 Earnings Report Preview: What To Expect","id":129054646,"image":"","symbol":"LH","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3579414984"},{"category":"company","date":1722420000,"headline":"Labcorp expands Ultima pact to boost genomic diagnostics","id":129044105,"image":"https://www.medtechdive.com/imgproxy/Oav5cafGTlg5Y3qKjAY7P_eRW46RkVaMpHPJoiymPtk/g:ce/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL0dldHR5SW1hZ2VzLTEzMDE2NDUxMjAuanBn.webp","symbol":"LH","publisher":"Yahoo","summary":"Labcorp will use Ultima Genomics’ UG 100, a machine designed to sequence the genome for $100, to assess molecular residual disease.","url":"https://www.medtechdive.com/news/labcorp-ultima-genomics-partnership-diagnostics/722863/"},{"category":"company","date":1722410760,"headline":"Notable companies reporting before tomorrow's open","id":129050844,"image":"","symbol":"LH","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3580276467"},{"category":"company","date":1722337200,"headline":"Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities","id":129001316,"image":"https://media.zenfs.com/en/prnewswire.com/6f6fbefcc001ce9df3fa4dee79b08190","symbol":"LH","publisher":"Yahoo","summary":"Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with Ultima Genomics to utilize its UG 100TM sequencing solution and ppmSeqTM technology to explore new whole genome sequencing (WGS) clinical applications, including molecular residual disease (MRD) in patients with early-stage solid tumor cancers.","url":"https://finance.yahoo.com/news/labcorp-expands-collaboration-ultima-genomics-110000929.html"},{"category":"company","date":1722319500,"headline":"Labcorp expands collaboration with Ultima Genomics in genome sequencing","id":129022527,"image":"","symbol":"LH","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577473394"}]}